These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6744290)

  • 1. Effect of growth on the estrogen receptor levels in MCF-7 cells.
    Brooks SC; Hansen ER; Saunders DE; Battelli MG; Shafie SM
    Cancer Res; 1984 Sep; 44(9):3724-9. PubMed ID: 6744290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrone receptor formation during the processing of estradiol-receptor complex in MCF-7 cells.
    Hansen ER; Brooks SC
    Cancer Res; 1982 May; 42(5):1967-74. PubMed ID: 7066908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
    Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA
    Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration.
    Briand P; Lykkesfeldt AE
    Cancer Res; 1984 Mar; 44(3):1114-9. PubMed ID: 6362856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of serum and insulin on the sensitivity of the human breast cancer cell line MCF-7 to estrogen and antiestrogens.
    Butler WB; Kelsey WH; Goran N
    Cancer Res; 1981 Jan; 41(1):82-8. PubMed ID: 7004631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a unique nuclear estrogen-binding component in an estrogen-responsive mouse Leydig cell tumor.
    Maeda Y; Sato B; Noma K; Kishimoto S; Koizumi K; Aono T; Matsumoto K
    Cancer Res; 1983 Sep; 43(9):4091-7. PubMed ID: 6871850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of an estrogen-inhibited variant derived from the MCF-7 breast cancer cell line.
    Bronzert DA; Triche TJ; Gleason P; Lippman ME
    Cancer Res; 1984 Sep; 44(9):3942-51. PubMed ID: 6744309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S; Krishnan AV; Feldman D
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged retention of estradiol by human breast cancer cells in tissue culture.
    Strobl JS; Lippman ME
    Cancer Res; 1979 Sep; 39(9):3319-27. PubMed ID: 476661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of MCF-7 cells overexpressing a transfected epidermal growth factor receptor (EGFR) under estrogen-depleted conditions: evidence for a role of EGFR in breast cancer growth and progression.
    Miller DL; el-Ashry D; Cheville AL; Liu Y; McLeskey SW; Kern FG
    Cell Growth Differ; 1994 Dec; 5(12):1263-74. PubMed ID: 7696175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen and 5-fluorouracil in breast cancer: cytotoxic synergism in vitro.
    Benz C; Cadman E; Gwin J; Wu T; Amara J; Eisenfeld A; Dannies P
    Cancer Res; 1983 Nov; 43(11):5298-303. PubMed ID: 6616464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of histochemical and biochemical assays for estrogen receptor in human breast cancer cell lines.
    Parl FF; Wetherall NT; Halter S; Schuffman S; Mitchell WM
    Cancer Res; 1984 Jan; 44(1):415-21. PubMed ID: 6690057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of estradiol immunofluorescence in MCF-7 breast cancer cells to detect estrogen receptors.
    Mercer WD; Edwards DP; Chamness GC; McGuire WL
    Cancer Res; 1981 Nov; 41(11 Pt 1):4644-52. PubMed ID: 7030480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
    Herman ME; Katzenellenbogen BS
    Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific estrogen receptor binding and biological effects of 16 alpha-iodoestradiol on human breast cancer cells.
    Lippman ME; Do HM; Hochberg RB
    Cancer Res; 1981 Aug; 41(8):3150-4. PubMed ID: 7248972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of prolactin on growth and the estrogen receptor level of human breast cancer cells (MCF-7).
    Shafie S; Brooks SC
    Cancer Res; 1977 Mar; 37(3):792-9. PubMed ID: 189915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiestrogen pharmacology and mechanism of action.
    Katzenellenbogen BS; Miller MA; Eckert RL; Sudo K
    J Steroid Biochem; 1983 Jul; 19(1A):59-68. PubMed ID: 6887873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of estrogen receptor concentration in MCF-7 human breast carcinoma cells following exposure to chemotherapeutic drugs.
    Yang KP; Samaan NA
    Cancer Res; 1983 Aug; 43(8):3534-8. PubMed ID: 6861126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen-induced apoptosis in a breast cancer model resistant to long-term estrogen withdrawal.
    Lewis JS; Osipo C; Meeke K; Jordan VC
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):131-41. PubMed ID: 15862958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug and hormone sensitivity of estrogen receptor-positive and -negative human breast cancer cells in vitro.
    Goldenberg GJ; Froese EK
    Cancer Res; 1982 Dec; 42(12):5147-51. PubMed ID: 7139616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.